Compare
Johnson & Johnson vs PTC Therapeutics (JNJ vs PTCT)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Johnson & Johnson (JNJ) returned +48.5% and PTC Therapeutics (PTCT) -8.8%; so far this year the figures are +33.5% and -13.8%.
Johnson & Johnson is the larger company by market value, about 121.6 times the size of PTC Therapeutics.
Revenue grew +7.8% at JNJ and -35.1% at PTCT over the last year.
JNJ yields 1.91%. PTCT pays no dividend.
Data as of the latest close. Not investment advice.
Relative performance
| JNJ | PTCT | |
|---|---|---|
| Price | $276.22 | $65.44 |
| 1-day | +1.43% | -0.35% |
| YTD | +33.47% | -13.85% |
| 1 year | +48.51% | -8.82% |
| 3 years | +85.77% | +254.69% |
| Market cap | $665.0B | $5.5B |
| P/E | 41.9 | — |
| P/S | 6.69 | 4.73 |
| P/B | 8.16 | — |
| Revenue growth | +7.80% | -35.10% |
| EPS growth | -36.40% | -116.40% |
| Gross margin % | 67.6 | 25.5 |
| Net margin % | 16.2 | -9.2 |
| ROE % | 19.7 | — |
| Debt / equity | 0.55 | — |
| FCF yield % | 3.1 | 0.0 |
| Dividend yield % | 1.91 | — |
| Beta | -0.09 | 0.82 |
| RSI (14) | 59.4 | 53.3 |
| Technical rating |